ADPT
NASD Adaptive Biotechnologies Corp.$28.90 ↑ +0.00 (+0.00%) Trading Up from the previous close of $28.90
- YTD change
- +77.96%
- vs 20-day SMA
- +7.84%
- vs 200-day SMA
- +55.92%
Price ranges
Price & Performance
+14.47 (+100.28%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 59.4% away from all-time highs of $71.25
- ADPT is up 78% since the beginning of the year
- ADPT is up 98% over the past 12 months
- ADPT is up 19% over the past 1 month
- 9% of all ADPT investors are betting against ADPT
ADPT reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +98.5%.
- Previous minute
- +$0.00
- Last hour
- -$0.60
- Last 5 days
- +3.62%
- vs 8-day SMA
- +0.96%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.